STAT NewsOriginal article
STAT+: Makers of rare disease drugs seek exemption from Trump’s price-cut pilots
RegulatoryOrphan drugsNegative
AI Analysis
Summary
A coalition of biotech firms is lobbying to exclude orphan drugs from new Trump administration federal pilot programs designed to reduce Medicare drug costs.
Outcome Details
Coalition seeking exemption from federal pilot programs for Medicare drug cost reduction
Importance:4/10
Sentiment:
-0.30
rare diseaseorphan drugspricingMedicareregulatorylobbying
Related Companies
Read the original article
Published by STAT News on July 21, 2026 8:30 AM